Meaning
Foreign investment screening acts as a mandatory regulatory gatekeeper within cross border corporate acquisitions, conditioning legal closing on prior administrative clearance from the State Administration for Market Regulation. This statutory jurisdiction applies directly to proposed transactions meeting specified domestic turnover thresholds or market share concentrations within the People Republic of China. Regulatory scrutiny evaluates potential anticompetitive effects on local product markets alongside broader national security considerations.
Official review authority expires outside designated statutory timeframes or when the agency formally clears the transaction structure.
Jurisdictional Scope
Statutory thresholds establish the precise boundaries for filing obligations in transactions involving multinational corporate groups. Combined global turnover or local turnover generated by participating entities within the domestic territory triggers mandatory notification. Foreign parent entities must aggregate figures from all controlled subsidiaries worldwide to determine whether their financial metrics cross the statutory line.
Transaction planners calculate these monetary values using audited financial statements from the preceding fiscal year.
Review Timeline
Administrative review operates through distinct phases that dictate the rhythm of cross border transaction scheduling. Initial preliminary examination grants clearance within a thirty day window if no substantive market dominance issues arise. Complex transactions trigger an extended further review phase lasting ninety days or longer depending on the cooperation of filing parties.
Parties cannot lawfully implement the transaction while the review clock runs without facing substantial financial penalties.
Conditional Clearance
Regulatory approval frequently incorporates binding commitments designed to mitigate perceived competitive harm in specific domestic sectors. Divestiture of overlapping production facilities or licensing of proprietary technology represents standard behavioral or structural remedies accepted by the agency. Parties negotiate these restrictive conditions through detailed written agreements that form part of the final clearance decision.
Noncompliance with remedy obligations permits the regulator to revoke prior approval and unwind the completed transaction structure.
